a year ago
MRNA
AnalystsEmmanuel PapadakisEmmanuel Papadakis's Stock Forecasts
AnalystsEmmanuel Papadakis
Analyst Ranking
Bottom 26%
#3162 out of 4237 analysts
Average Return
-4.83%
Win Rate
33%2 out of 6
Risk vs Reward
Poor
Good
Emmanuel Papadakis Analyst Color
Get additional color on Emmanuel Papadakis's coverage of popular stocks
Emmanuel Papadakis's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Biontech SeBNTX | 4 | Hold | $120.00 | +10.98% | Maintains | 18 days ago |
AlvotechALVO | 2 | Hold | $12.00 | +41.34% | Maintains | 3 months ago |
Moderna IncMRNA | 4 | Strong Buy | $200.00 | +53.24% | Maintains | 3 months ago |
SanofiSNY | 3 | Hold | N/A | N/A | Upgrades | 10 months ago |
Curevac NvCVAC | 1 | Hold | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Novartis AgNVS | 4 | Strong Sell | N/A | N/A | Downgrades | 2 years ago |
Argenx SeARGX | 1 | Hold | N/A | N/A | Initiates Coverage On | 2 years ago |
Ucb SaUCBJY | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 2 years ago |
Roche Holding LtdRHHBY | 1 | Strong Buy | N/A | N/A | Upgrades | 2 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.